SJ-6986

N/A

Report date: 2022/10/25 13:04:48
NME

Base Information

Drug NameSJ-6986
Drug Alias NameSJ-6986
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic peptide chain release factor GTP-binding subunit ERF3A degradersImmunomodulatorsEGFR T790M inhibitors
TargetsEukaryotic peptide chain release factor GTP-binding subunit ERF3AEGFR T790M
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSt. Jude Children'S Research Hospital
China Registration ClassN/A

Develop Information

Active CompaniesSt. Jude Children'S Research Hospital
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A